Anti-cancer Agents In Medicinal Chemistry

Anti-cancer Agents In Medicinal Chemistry

药物化学中的抗癌剂

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Anti-cancer Agents In Medicinal Chemistry》是由Bentham Science Publishers B.V.出版社于2006年创办的英文国际期刊(ISSN: 1871-5206,E-ISSN: 1875-5992),该期刊长期致力于药物化学领域的创新研究,主要研究方向为ONCOLOGY-CHEMISTRY, MEDICINAL。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比68.16%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在201篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Anti-cancer Agents In Medicinal Chemistry审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约201篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 201 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学 ONCOLOGY 肿瘤学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学 ONCOLOGY 肿瘤学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 44 / 72

39.6%

学科:ONCOLOGY SCIE Q3 175 / 322

45.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 46 / 72

36.81%

学科:ONCOLOGY SCIE Q3 180 / 322

44.25%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.1 SJR:0.503 SNIP:0.547
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 149 / 313

52%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Cancer Research Q3 132 / 230

42%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q3 105 / 178

41%

期刊发文

  • Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/beta-Catenin Signaling

    Author: Zhang, Lingzhao; Chen, Jiayi; Chen, Yangmei; Zou, Daopei; Pu, Yihuan; Wei, Mengqi; Huang, Yanran; Li, Yuxin; Huang, Qing; Chen, Jin

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 1, pp. 94-104. DOI: 10.2174/1871520622666220519100054

  • Novel Potent EGFR-JAK3 Dual-Target Inhibitor that Overcomes KRAS Mutation Resistance in Colorectal Cancer

    Author: Wu, Tingyu; Yu, Jiawen; Wang, Changyuan; Jin, Yue; Zheng, Xu; Chen, Lixue; Ma, Xiaodong; Sun, Xiuli

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 4, pp. 440-449. DOI: 10.2174/1871520622666220609112816

  • Advances in the Study of Hexokinase 2 (HK2) Inhibitors

    Author: Wang, Shaopei; Zhuang, Yan; Xu, Jindan; Tong, Yan; Li, Xiaofei; Dong, Chunhong

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 736-746. DOI: 10.2174/1871520623666221020092423

  • Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment

    Author: Ullah, Asmat; Ullah, Najeeb; Nawaz, Touseef; Aziz, Tariq

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 765-778. DOI: 10.2174/1871520622666220831124321

  • The Synergistic Anti-colon Cancer Effect of Aurora A Inhibitors and AKT Inhibitors Through PI3K/AKT Pathway

    Author: Sun, Cheng; Qu, Zhen; Liu, Weilin; Qiu, Zhigang; Lu, Yanfeng; Sun, Zhenqing

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 1, pp. 87-93. DOI: 10.2174/1871520622666220422133537

  • Ganoderic Acid A Enhances Tumor Suppression Function of Oxaliplatin via Inducing the Cytotoxicity of T Cells

    Author: Song, Zhichao; Wang, Chunhui; Ding, Fei; Zou, Hao; Liu, Chengkui

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 832-838. DOI: 10.2174/1871520623666221103110934

  • Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast Cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1 alpha

    Author: Qiu, Jian; Shen, Zhongyi; Jiang, Guoqin; Ni, Qichao

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 4, pp. 470-477. DOI: 10.2174/1871520622666220817125817

  • Tanshinone IIA Alleviates the Biological Characteristics of Colorectal Cancer via Activating the ROS/JNK Signaling Pathway

    Author: Qian, Jun; Cao, Yi; Zhang, Junfeng; Li, Lingchang; Wu, Juan; Yu, Jialin; Huo, Jiege

    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 2, pp. 227-236. DOI: 10.2174/1871520622666220421093430